Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2010 3
2011 3
2012 5
2013 5
2014 7
2015 4
2016 3
2017 8
2018 14
2019 6
2020 10
2021 16
2022 6
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Mucopolysaccharidosis Type I.
Kubaski F, de Oliveira Poswar F, Michelin-Tirelli K, Matte UDS, Horovitz DD, Barth AL, Baldo G, Vairo F, Giugliani R. Kubaski F, et al. Among authors: baldo g. Diagnostics (Basel). 2020 Mar 16;10(3):161. doi: 10.3390/diagnostics10030161. Diagnostics (Basel). 2020. PMID: 32188113 Free PMC article. Review.
In Situ Gene Therapy.
Santos HS, Rodrigues L, Vera LNP, Poletto E, Filippi-Chiela E, Dos Santos Bruschi LFR, Schuh R, Baldo G. Santos HS, et al. Among authors: baldo g. Curr Gene Ther. 2021;21(5):406-430. doi: 10.2174/1566523221666210504103323. Curr Gene Ther. 2021. PMID: 33949931 Review.
Genome Editing for Mucopolysaccharidoses.
Poletto E, Baldo G, Gomez-Ospina N. Poletto E, et al. Among authors: baldo g. Int J Mol Sci. 2020 Jan 13;21(2):500. doi: 10.3390/ijms21020500. Int J Mol Sci. 2020. PMID: 31941077 Free PMC article. Review.
Precision Medicine for Lysosomal Disorders.
Pinto E Vairo F, Rojas Málaga D, Kubaski F, Fischinger Moura de Souza C, de Oliveira Poswar F, Baldo G, Giugliani R. Pinto E Vairo F, et al. Among authors: baldo g. Biomolecules. 2020 Jul 26;10(8):1110. doi: 10.3390/biom10081110. Biomolecules. 2020. PMID: 32722587 Free PMC article. Review.
Therapeutic Options for Mucopolysaccharidosis II (Hunter Disease).
Kubaski F, Vairo F, Baldo G, de Oliveira Poswar F, Corte AD, Giugliani R. Kubaski F, et al. Among authors: baldo g. Curr Pharm Des. 2020;26(40):5100-5109. doi: 10.2174/1381612826666200724161504. Curr Pharm Des. 2020. PMID: 33138761 Review.
Nanotechnology applied to treatment of mucopolysaccharidoses.
Schuh RS, Baldo G, Teixeira HF. Schuh RS, et al. Among authors: baldo g. Expert Opin Drug Deliv. 2016 Dec;13(12):1709-1718. doi: 10.1080/17425247.2016.1202235. Epub 2016 Jun 30. Expert Opin Drug Deliv. 2016. PMID: 27322551 Review.
Emerging drugs for the treatment of mucopolysaccharidoses.
Giugliani R, Federhen A, Vairo F, Vanzella C, Pasqualim G, da Silva LM, Giugliani L, de Boer AP, de Souza CF, Matte U, Baldo G. Giugliani R, et al. Among authors: baldo g. Expert Opin Emerg Drugs. 2016;21(1):9-26. doi: 10.1517/14728214.2016.1123690. Epub 2016 Jan 9. Expert Opin Emerg Drugs. 2016. PMID: 26751109 Review.
Genome editing in lysosomal disorders.
Pimentel-Vera LN, Poletto E, Gonzalez EA, de Oliveira Poswar F, Giugliani R, Baldo G. Pimentel-Vera LN, et al. Among authors: baldo g. Prog Mol Biol Transl Sci. 2021;182:289-325. doi: 10.1016/bs.pmbts.2021.02.001. Epub 2021 Feb 22. Prog Mol Biol Transl Sci. 2021. PMID: 34175045
Genome editing in mucopolysaccharidoses and mucolipidoses.
Santos HS, Poletto E, Schuh R, Matte U, Baldo G. Santos HS, et al. Among authors: baldo g. Prog Mol Biol Transl Sci. 2021;182:327-351. doi: 10.1016/bs.pmbts.2021.01.026. Epub 2021 Mar 1. Prog Mol Biol Transl Sci. 2021. PMID: 34175047
90 results